tiprankstipranks
Advertisement
Advertisement

HK:2637 Stock Latest News

Fujian Haixi Pharmaceuticals Board Sets Date to Approve Interim Results and Mull Dividend
Company AnnouncementsFujian Haixi Pharmaceuticals Board Sets Date to Approve Interim Results and Mull Dividend
4d ago
2637
Fujian Haixi Pharmaceuticals shifts auditor as it adopts Chinese accounting standards
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals shifts auditor as it adopts Chinese accounting standards
5d ago
2637
Haixi Pharmaceuticals Advances Oral nAMD Drug HX9428 With U.S. FDA Nod and New China Trial
PremiumCompany Announcements
Haixi Pharmaceuticals Advances Oral nAMD Drug HX9428 With U.S. FDA Nod and New China Trial
12d ago
2637
Fujian Haixi Pharma Shareholders Back Auditor Switch and New Executive Director
PremiumCompany Announcements
Fujian Haixi Pharma Shareholders Back Auditor Switch and New Executive Director
12d ago
2637
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
12d ago
2637
Fujian Haixi Pharmaceuticals Details Significant 2025 Investment Portfolio
PremiumCompany AnnouncementsFujian Haixi Pharmaceuticals Details Significant 2025 Investment Portfolio
13d ago
2637
Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role
Premium
Company Announcements
Fujian Haixi Pharma Reshapes Board, Elevates Marketing Chief to Executive Role
1M ago
2637
Fujian Haixi Pharmaceuticals Sets Formal Nomination Committee to Strengthen Board Governance
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Sets Formal Nomination Committee to Strengthen Board Governance
1M ago
2637
Fujian Haixi Pharma Calls 2026 EGM to Approve Auditor Change and New Director
PremiumCompany Announcements
Fujian Haixi Pharma Calls 2026 EGM to Approve Auditor Change and New Director
1M ago
2637
Fujian Haixi Pharmaceuticals to Adopt CASBE and Switch Auditor to RSM China
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals to Adopt CASBE and Switch Auditor to RSM China
1M ago
2637
Haixi Pharma Wins NMPA Clearance for New Glioblastoma Drug HXP089
PremiumCompany Announcements
Haixi Pharma Wins NMPA Clearance for New Glioblastoma Drug HXP089
1M ago
2637
Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug
PremiumCompany Announcements
Haixi Pharmaceuticals Launches Phase III Trial for Novel Osteosarcoma Drug
1M ago
2637
Haixi Pharma Initiated at Buy on Innovative Retinal and Oncology Pipeline; DCF‑Backed Target Price Set at HK$280
PremiumRatingsHaixi Pharma Initiated at Buy on Innovative Retinal and Oncology Pipeline; DCF‑Backed Target Price Set at HK$280
2M ago
Fujian Haixi Pharmaceuticals Overhauls Governance as Shareholders Back All AGM Resolutions
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Overhauls Governance as Shareholders Back All AGM Resolutions
3M ago
2637
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Details Board and Committee Structure
3M ago
2637
Fujian Haixi Pharma AGM to Vote on Governance Overhaul, New Board and Incentive Plan
PremiumCompany Announcements
Fujian Haixi Pharma AGM to Vote on Governance Overhaul, New Board and Incentive Plan
4M ago
2637
Fujian Haixi Pharma Proposes H-Share Incentive Scheme for Core Staff
PremiumCompany Announcements
Fujian Haixi Pharma Proposes H-Share Incentive Scheme for Core Staff
4M ago
2637
Fujian Haixi Pharmaceuticals Delivers Double-Digit Profit Growth in 2025
PremiumCompany Announcements
Fujian Haixi Pharmaceuticals Delivers Double-Digit Profit Growth in 2025
5M ago
2637
Fujian Haixi Advances First-in-Class Oral Retinal Drug HXP056 Into Phase II
PremiumCompany Announcements
Fujian Haixi Advances First-in-Class Oral Retinal Drug HXP056 Into Phase II
5M ago
2637
Fujian Haixi Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend
PremiumCompany AnnouncementsFujian Haixi Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final Dividend
5M ago
2637
Fujian Haixi Pharmaceuticals Revamps Hong Kong Company Secretarial Roles
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Revamps Hong Kong Company Secretarial Roles
5M ago
2637
Fujian Haixi Pharmaceuticals Names Veteran Global R&D Leader as President
Premium
Company Announcements
Fujian Haixi Pharmaceuticals Names Veteran Global R&D Leader as President
6M ago
2637

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >